Pcn146 - Inotuzumab Ozogamicin in Patients With Relapsed or Refractory (R/R) Acute Lymphocytic Leukemia (All): Establishing a Value-Based Cost – Preliminary Results

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.229
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV